GSK has reported new clinical data pointing to a benefit with its respiratory syncytial virus (RSV) vaccine Arexvy when used to treat a younger age group than the over-60s for whom it is approved.

The FDA has started a review of MSD's respiratory syncytial virus (RSV) antibody clesrovimab, with a verdict due in the middle of next year. If approved by the 10th June action date, clesrovimab ...

Pink-red, scaly rash on inner thighs near groin. Often, starts in the groin crease. Then, spreads slowly downward. In boys, the rash does not involve the penis or scrotum. Rash is most often the same ...